AMENDED: Continued Growth Momentum into Q1 FY22

Amended release: Clarifying the increases disclosed on the preceding quarter. For lab throughput 109% increase on the preceding quarter amended to 109% on the previous quarter. For cash receipts from customers 121% increase on the preceding quarter amended to 121% on the previous quarter. End CA:00376409 For:PEB Type:GENERAL Time:2021-07-29 10:25:16